Plasmapp Co. Ltd.

As of June 30, 2026, Plasmapp Co. Ltd. carries a market capitalization of 15.04B, placing it among publicly traded companies globally. Its enterprise value stands at 25.49B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Plasmapp Co. Ltd. has 3.84M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 1.15, and the price-to-book ratio stands at 11.48.

These figures are as of June 30, 2026. The EV/Sales ratio of 2.12 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 25.49B versus a market cap of 15.04B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Plasmapp Co. Ltd. maintains a current ratio of 0.92, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 991.21, indicating elevated leverage, while an interest coverage ratio of -4.25 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Plasmapp Co. Ltd. posted a negative return on equity (ROE) of -154.60, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -38.51, reflecting losses generated across the asset base. The company generates approximately 209.89M in revenue per employee across its workforce of 57.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.60 indicates how many times Plasmapp Co. Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 23, 2026, Plasmapp Co. Ltd.'s stock has declined approximately 57.23% over the past 52 weeks. The 50-day moving average sits at 3,710.40, while the 200-day moving average is 5,379.68.

Over the twelve months ended June 30, 2026, Plasmapp Co. Ltd. generated 12.02B in revenue and converted that into -7.73B in net income, yielding earnings per share of -2,189.41. EBITDA reached -5.96B, while operating income came in at -7.09B.

As of June 30, 2026, Plasmapp Co. Ltd. holds 2.54B in cash and equivalents against 12.99B in total debt, resulting in a net debt position of 10.20B. Total book value stands at 1.31B, with working capital of -1.11B providing operational flexibility.

Plasmapp Co. Ltd. produced -8.48B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -202.00M in capital expenditures, free cash flow totaled -8.68B - equivalent to -2,458.72 per share.

Over the twelve months ended June 30, 2026, Plasmapp Co. Ltd. posted a gross margin of 14.79, reflecting its pricing power and cost economics. The operating margin of -58.97 and net profit margin of -64.31 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -62.72: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -28.40, meaning Plasmapp Co. Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Plasmapp Co. Ltd.'s most recent stock split took place on May 9, 2025 with a 10:1 split ratio.

As of June 30, 2026, Plasmapp Co. Ltd. has an Altman Z-Score of -0.72, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.